Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

As CLL treatment paradigms continue to shift and become more complex, it is essential to provide patients with education on available treatment options and to engage in open discussions about their care. In this expert commentary, best practices on these concepts are discussed.

Jennifer Woyach, MD Released: November 17, 2021

Review an expert discussion of investigational treatment strategies for patients with chronic lymphocytic leukemia, including novel BTK and PI3K inhibitors, combination treatment with BTK and BCL-2 inhibitors, and CAR T-cell therapy.

Shuo Ma, MD, PhD Released: April 21, 2022

In this commentary, an expert faculty discusses key considerations and shared decision-making in choosing treatment for a patient with CLL.

Lindsey Roeker, MD Released: July 7, 2022

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with CLL with those of 5 renowned experts.

Farrukh Awan, MD Jennifer R. Brown, MD, PhD Nicole Lamanna, MD Anthony Mato, MD, MSCE Jeff Sharman, MD Released: September 22, 2022

In this interactive virtual presentation, expert faculty discuss the latest information on measurable residual disease testing and its clinical use in the care of patients with CLL.

Jennifer Woyach, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 22, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on measurable residual disease testing and clinical use in the care of patients with CLL.

Jennifer Woyach, MD Released: July 22, 2022

In this interactive virtual presentation, a leading CLL patient advocate and healthcare professional discusses common issues of concern for patients who have been diagnosed with CLL and best practices in patient education.

Brian Koffman, MDCM (retired), MS Ed Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: June 10, 2022 Expired: No longer available for credit

Download this slideset, in which a leading CLL patient advocate and healthcare professional outlines common issues of concern for patients who have been diagnosed with CLL and best practices in patient education.

Brian Koffman, MDCM (retired), MS Ed Released: June 13, 2022

In this interactive virtual presentation, expert faculty discuss how treatment for CLL has evolved rapidly over the past 5 years, with case studies used to illustrate current therapeutic paradigms.

Nicole Lamanna, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 15, 2022 Expired: No longer available for credit

Download this slideset, in which an expert faculty discusses how treatment for CLL has evolved over the past 5 years.

Nicole Lamanna, MD Released: August 15, 2022

In this interactive virtual presentation, expert faculty discuss considerations for selecting optimal first-line treatment for patients with CLL, with a focus on key elements of patient education.

Jennifer Woyach, MD
Program Director Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 4, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on best practices in treating patients with newly diagnosed CLL.

Jennifer Woyach, MD Released: March 4, 2022

In this interactive virtual presentation, expert faculty discuss best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.

Nicole Lamanna, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 17, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.

Nicole Lamanna, MD Released: March 17, 2022

In this interactive virtual presentation, expert faculty discuss common CLL-related symptoms and best practices in identifying and managing key adverse events associated with BTK inhibitors in patients with CLL.

Nicole Lamanna, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 5, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on best practices in identifying and managing key adverse events commonly associated with BTK inhibitors in patients with CLL.

Nicole Lamanna, MD Released: April 5, 2022

In this focused text module, multidisciplinary expert faculty discuss how treatment for CLL has evolved rapidly during the past 5 years and how this has affected clinical practice, with case studies used to illustrate current therapeutic paradigms.

Nichole Fisher, RN, BSN Nicole Lamanna, MD Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: October 6, 2022 Expired: No longer available for credit

In this focused, case-based text module, expert faculty review key trial data and patient-specific factors important to selecting optimal frontline therapy for patients with CLL.

Nichole Fisher, RN, BSN Anthony Perissinotti, PharmD, BCOP Jennifer Woyach, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: April 19, 2022 Expired: No longer available for credit

In this focused text module, a pharmacist, nurse, and leading CLL patient advocate and healthcare professional discuss common issues of concern for patients who have been diagnosed with CLL and best practices in patient education.

Nichole Fisher, RN, BSN Brian Koffman, MDCM (retired), MS Ed Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: August 17, 2022 Expired: No longer available for credit

In this focused text module, expert faculty discuss the latest information on measurable residual disease testing and clinical use in the care of patients with CLL.

Nichole Fisher, RN, BSN Anthony Perissinotti, PharmD, BCOP Jennifer Woyach, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: August 30, 2022 Expired: No longer available for credit

In this focused, case-based text module, multidisciplinary expert faculty review best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.

Nichole Fisher, RN, BSN Nicole Lamanna, MD Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 19, 2022 Expired: No longer available for credit

In this focused, case-based text module, multidisciplinary expert faculty review common CLL-related symptoms and best practices in identifying and managing key adverse events commonly associated with BTK inhibitors in patients with CLL.

Nichole Fisher, RN, BSN Nicole Lamanna, MD Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: May 31, 2022 Expired: No longer available for credit